The infertile patients with aging ovaries—also sometimes referred to as impending
premature ovarian insufficiency (POI), impending premature ovarian failure (POF), or poor …

Growth hormone (GH) has been used as an adjunct in the field of female infertility treatment
for more than 25 years, although, apart from treating women with GH deficiency its role has …

Objective To discuss the value of double stimulations and mild ovarian stimulation combined
with Gn-RH-antagonist in patients with decreased ovarian reserve receiving in vitro …

STUDY QUESTION In subfertile women with poor ovarian reserve undergoing IVF does a
mild ovarian stimulation strategy lead to comparable ongoing pregnancy rates in …

Background Patients found to be poor ovarian responders (POR) are a challenging patient
population for any assisted reproduction technology. Despite attempts at various controlled …

Growth hormone (GH) is involved in the regulation of male and female infertility. Several
clinical studies reveal that adjuvant GH treatment has a possible role in vitro fertilization …

The current study aimed to investigate the effects of luteal gonadotropin-releasing hormone
(GnRH) antagonist pretreatment on the outcomes of diminished ovarian reserve (DOR) …

Objective To analyze the association between oocyte quality and decreased ovarian reserve
(DOR) markers in young women undergoing controlled ovarian stimulation (COS). Methods …

To compare the effect of the different protocols in patients receiving in vitro fertilization
treatment due to poor ovarian response. Seventy-seven of the patients included in the study …

Failure of the ovaries to respond to gonadotropin stimulation is a negative prognostic factor
that may indicate reduced ovarian reserve. Simultaneous evaluation of basal FSH and E2 …